Phenotypic clustering in MPZ mutations

被引:220
作者
Shy, ME
Jáni, A
Krajewski, K
Grandis, M
Lewis, RA
Li, J
Shy, RR
Balsamo, J
Lilien, J
Garbern, JY
Kamholz, J
机构
[1] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA
[3] Childrens Hosp Michigan, Dept Pediat, Detroit, MI 48201 USA
[4] Univ Iowa, Dept Biol Sci, Iowa City, IA USA
关键词
MPZ; CMT1B; phenotype; myelin; PNS;
D O I
10.1093/brain/awh048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myelin protein zero (MPZ) is a member of the immunoglobulin gene superfamily with single extracellular, transmembrane and cytoplasmic domains. Homotypic interactions between extracellular domains of MPZ adhere adjacent myelin wraps to each other. MPZ is also necessary for myelin compaction since mice which lack MPZ develop severe dysmyelinating neuropathies in which compaction is dramatically disrupted. MPZ mutations in humans cause the inherited demyelinating neuropathy CMT1B. Some mutations cause the severe neuropathies of infancy designated as Dejerine-Sottas disease, while others cause a 'classical' Charcot-Marie-Tooth (CMT) disease Type 1B (CMT1B) phenotype with normal early milestones but development of disability during the first two decades of life. Still other mutations cause a neuropathy that presents in adults, with normal nerve conduction velocities, designated as a 'CMT2' form of CMT1B. To correlate the phenotype of patients with MPZ mutations with their genotype, we identified and evaluated 13 patients from 12 different families with eight different MPZ mutations. In addition, we re-analysed the clinical data from 64 cases of CMT1B from the literature. Contrary to our expectations, we found that most patients presented with either an early onset neuropathy with signs and symptoms prior to the onset of walking or a late onset neuropathy with signs and symptoms at around age 40 years. Only occasional patients presented with a 'classical' CMT phenotype. Correlation of specific MPZ mutations with their phenotypes demonstrated that addition of either a charged amino acid or altering a cysteine residue in the extracellular domain caused a severe early onset neuropathy. Severe neuropathy was also caused by truncation of the cytoplasmic domain or alteration of an evolutionarily conserved amino acid. Taken together, these data suggest that early onset neuropathy is caused by MPZ mutations that significantly disrupt the tertiary structure of MPZ and thus interfere with MPZ-mediated adhesion and myelin compaction. In contrast, late onset neuropathy is caused by mutations that more subtly alter myelin structure and which probably disrupt Schwann cell-axonal interactions.
引用
收藏
页码:371 / 384
页数:14
相关论文
共 83 条
  • [1] ABNORMAL MYELINATION IN TRANSPLANTED TREMBLER MOUSE SCHWANN-CELLS
    AGUAYO, AJ
    ATTIWELL, M
    TRECARTEN, J
    PERKINS, S
    BRAY, GM
    [J]. NATURE, 1977, 265 (5589) : 73 - 75
  • [2] Two amino-acid substitutions in the myelin protein zero gene of a case of Charcot-Marie-Tooth disease associated with light-near dissociation
    Bienfait, HME
    Baas, F
    Gabreëls-Festen, AAWM
    Koelman, JHTM
    Langerhorst, CT
    de Visser, M
    [J]. NEUROMUSCULAR DISORDERS, 2002, 12 (03) : 281 - 285
  • [3] Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: A 20-year study
    Bird, TD
    Kraft, GH
    Lipe, HP
    Kenney, KL
    Sumi, SM
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (04) : 463 - 469
  • [4] BlanquetGrossard E, 1996, HUM MUTAT, V8, P185
  • [5] BlanquetGrossard F, 1995, CLIN GENET, V48, P281
  • [6] Charcot-Marie-Tooth disease and related neuropathies: Mutation distribution and genotype-phenotype correlation
    Boerkoel, CF
    Takashima, H
    Garcia, CA
    Olney, RK
    Johnson, J
    Berry, K
    Russo, P
    Kennedy, S
    Teebi, AS
    Scavina, M
    Williams, LL
    Mancias, P
    Butler, IJ
    Krajewski, K
    Shy, M
    Lupski, JR
    [J]. ANNALS OF NEUROLOGY, 2002, 51 (02) : 190 - 201
  • [7] Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene
    Chapon, F
    Latour, P
    Diraison, P
    Schaeffer, S
    Vandenberghe, A
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (06) : 779 - 782
  • [8] Total neuropathy score - Validation and reliability study
    Cornblath, DR
    Chaudhry, V
    Carter, K
    Lee, D
    Seysedadr, M
    Miernicki, M
    Joh, T
    [J]. NEUROLOGY, 1999, 53 (08) : 1660 - 1664
  • [9] The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype
    De Jonghe, P
    Timmerman, V
    Ceuterick, C
    Nelis, E
    De Vriendt, E
    Löfgren, A
    Vercruyssen, A
    Verellen, C
    Van Maldergem, L
    Martin, JJ
    Van Broeckhoven, C
    [J]. BRAIN, 1999, 122 : 281 - 290
  • [10] DEWAEGH S, 1990, J NEUROSCI, V10, P1855